返回
Epigenomics AG（EPGNF）價格
EPGNF 股價走勢圖
EPGNF 收益
Epigenomics AG
$1.12
0%
$0
截至今日：Jan 20, 11:20:40 GMT-5
關鍵數據
前收市價
$1.12
開盤價
$1.12
當日範圍
$1.12 - $1.12
52週區間
$0.79 - $1.12
交易量
380
平均成交量
0
每股盈餘 (TTM)
-3.69
股息收益率
--
市值
$982.1K
什麼是 EPGNF？
Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. The company is headquartered in Heidelberg, Baden-Wuerttemberg and currently employs 3 full-time employees. The company went IPO on 2004-07-19. The company develops and commercializes blood-based diagnostic products across multiple cancer indications. The firm's main product is Epi proColon, a blood test for colorectal cancer screening. Along with the blood-based tests the Company offers services related to research, product development, regulatory approval and manufacturing of in-vitro diagnostic (IVD) products. The company also offers Epi proLung, a blood-based test that detects the presence of lung cancer in blood plasma. The firm is present in Europe and the United States.